Literature DB >> 24554665

Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Shih-Hsin Chiu1, Meng-Chuan Wu, Chung-Chun Wu, Yu-Ching Chen, Su-Fang Lin, John T-A Hsu, Chung-Shi Yang, Ching-Hwa Tsai, Kenzo Takada, Mei-Ru Chen, Jen-Yang Chen.   

Abstract

UNLABELLED: Epstein-Barr virus (EBV) lytic replication involves complex processes, including DNA synthesis, DNA cleavage and packaging, and virion egress. These processes require many different lytic gene products, but the mechanisms of their actions remain unclear, especially for DNA cleavage and packaging. According to sequence homology analysis, EBV BALF3, encoded by the third leftward open reading frame of the BamHI-A fragment in the viral genome, is a homologue of herpes simplex virus type 1 UL28. This gene product is believed to possess the properties of a terminase, such as nucleolytic activity on newly synthesized viral DNA and translocation of unit length viral genomes into procapsids. In order to characterize EBV BALF3, the protein was produced by and purified from recombinant baculoviruses and examined in an enzymatic reaction in vitro, which determined that EBV BALF3 acts as an endonuclease and its activity is modulated by Mg(2+), Mn(2+), and ATP. Moreover, in EBV-positive epithelial cells, BALF3 was expressed and transported from the cytoplasm into the nucleus following induction of the lytic cycle, and gene silencing of BALF3 caused a reduction of DNA packaging and virion release. Interestingly, suppression of BALF3 expression also decreased the efficiency of DNA synthesis. On the basis of these results, we suggest that EBV BALF3 is involved simultaneously in DNA synthesis and packaging and is required for the production of mature virions. IMPORTANCE: Virus lytic replication is essential to produce infectious virions, which is responsible for virus survival and spread. This work shows that an uncharacterized gene product of the human herpesvirus Epstein-Barr virus (EBV), BALF3, is expressed during the lytic cycle. In addition, BALF3 mediates an endonucleolytic reaction and is involved in viral DNA synthesis and packaging, leading to influence on the production of mature virions. According to sequence homology and physical properties, the lytic gene product BALF3 is considered a terminase in EBV. These findings identify a novel viral gene with an important role in contributing to a better understanding of the EBV life cycle.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24554665      PMCID: PMC3993834          DOI: 10.1128/JVI.00063-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  90 in total

1.  Point mutations in exon I of the herpes simplex virus putative terminase subunit, UL15, indicate that the most conserved residues are essential for cleavage and packaging.

Authors:  Angela J Przech; Dong Yu; Sandra K Weller
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Insights into the structure of human cytomegalovirus large terminase subunit pUL56.

Authors:  Christos G W Savva; Andreas Holzenburg; Elke Bogner
Journal:  FEBS Lett       Date:  2004-04-09       Impact factor: 4.124

3.  Terminal repetitions in herpes simplex virus type 1 DNA.

Authors:  R H Grafstrom; J C Alwine; W L Steinhart; C W Hill
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Inverted repetitions in the chromosome of herpes simplex virus.

Authors:  P Sheldrick; N Berthelot
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

5.  Plasmid DNA as a possible state of Epstein-Barr virus genomes in nonproductive cells.

Authors:  M Nonoyama; A Tanaka
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

6.  Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions.

Authors:  S Wadsworth; R J Jacob; B Roizman
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

7.  Anatomy of herpes simplex virus DNA. V. Terminally repetitive sequences.

Authors:  S Wadsworth; G S Hayward; B Roizman
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

8.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

9.  Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1972-08-09

10.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

View more
  11 in total

1.  EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

Authors:  Nara Lee; Walter N Moss; Therese A Yario; Joan A Steitz
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

2.  Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification.

Authors:  Cheng-Wei Li; Bo-Ren Jheng; Bor-Sen Chen
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

3.  Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation.

Authors:  Melissa A Visalli; Brittany L House; Frances J Lahrman; Robert J Visalli
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

Review 4.  The lytic phase of Epstein-Barr virus plays an important role in tumorigenesis.

Authors:  Yue Liang; Yan Zhang; Bing Luo
Journal:  Virus Genes       Date:  2022-10-15       Impact factor: 2.198

5.  Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Authors:  Shih-Hsin Chiu; Chung-Chun Wu; Chih-Yeu Fang; Shu-Ling Yu; Hui-Yu Hsu; Yen-Hung Chow; Jen-Yang Chen
Journal:  Oncotarget       Date:  2014-09-30

6.  Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.

Authors:  Chung-Chun Wu; Chih-Yeu Fang; Sheng-Yen Huang; Shih-Hsin Chiu; Chia-Huei Lee; Jen-Yang Chen
Journal:  Cancers (Basel)       Date:  2018-04-17       Impact factor: 6.639

7.  The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.

Authors:  Sarah M Morgan; Hideki Tanizawa; Lisa Beatrice Caruso; Michael Hulse; Andrew Kossenkov; Jozef Madzo; Kelsey Keith; Yinfei Tan; Sarah Boyle; Paul M Lieberman; Italo Tempera
Journal:  Nat Commun       Date:  2022-01-17       Impact factor: 17.694

8.  Kaposi's Sarcoma-Associated Herpesvirus ORF7 Is Essential for Virus Production.

Authors:  Yuki Iwaisako; Tadashi Watanabe; Mizuki Hanajiri; Yuichi Sekine; Masahiro Fujimuro
Journal:  Microorganisms       Date:  2021-05-28

9.  Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97.

Authors:  Jens Milbradt; Eric Sonntag; Sabrina Wagner; Hanife Strojan; Christina Wangen; Tihana Lenac Rovis; Berislav Lisnic; Stipan Jonjic; Heinrich Sticht; William J Britt; Ursula Schlötzer-Schrehardt; Manfred Marschall
Journal:  Viruses       Date:  2018-01-13       Impact factor: 5.048

Review 10.  Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.

Authors:  Hongde Li; Jianmin Hu; Xiangjian Luo; Ann M Bode; Zigang Dong; Ya Cao
Journal:  Cancer Sci       Date:  2018-06-13       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.